Trial intelligence / Profile preview

ASCT vs Interferon Alpha in Advanced Mantle Cell Lymphoma

NCT00016887Phase 3Unknown

Sponsor
German Low-Grade Lymphoma Study Group
Start
Dec 2000
Modality
Cytokines & Interferons
Countries
2
01

Overview

A Phase 3 trial of interferon alfa in mantle cell lymphoma (MCL), sponsored by German Low-Grade Lymphoma Study Group. Status: unknown.

02

Drugs

interferon alfa
03

Conditions

mantle cell lymphoma (MCL)

Beyond the preview

Go deeper on NCT00016887.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00016887.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call